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The post-translationally modified, antimicrobial pep-
tide nisin is secreted by strains of Lactococcus lactis
that contain the chromosomally located nisin biosyn-
thetic gene cluster nisABTCIPRKFEG. When a 4-base
pair deletion is introduced into the structural nisA gene
(DnisA), transcription of DnisA is abolished. Transcrip-
tion of the DnisA gene is restored by adding subinhibi-
tory amounts of nisin, nisin mutants, or nisin analogs to
the culture medium, but not by the unmodified precur-
sor peptide or by several other antimicrobial peptides.
Upon disruption of the nisK gene, which encodes a pu-
tative sensor protein that belongs to the class of two-
component regulators, transcription of DnisA was no
longer inducible by nisin. Fusion of a nisA promoter
fragment to the promoterless reporter gene gusA re-
sulted in expression of gusA in L. lactis NZ9800 (DnisA)
only upon induction with nisin species. The expression
level of gusA was directly related to the amount of in-
ducer that was added extracellularly. These results pro-
vide insight into a new mechanism of autoregulation
through signal transduction in prokaryotes and demon-
strate that antimicrobial peptides can exert a second
function as signaling molecules.
Nisin is an antimicrobial peptide (1–3) widely used in the
food industry as a safe and natural preservative. The riboso-
mally synthesized precursor peptide undergoes extensive post-
translational modification, which includes dehydration of ser-
ine and threonine residues and the formation of thioether
bridges called (b-methyl)lanthionines, resulting in five ring
structures named A, B, C, D, and E (Fig. 1B). Peptides contain-
ing these characteristic modified residues are named lantibiot-
ics (4). Eleven genes organized in a cluster have been impli-
cated to be involved in the complex biosynthesis of nisin, i.e.
nisABTCIPRKFEG (Fig. 1A) (5–11). Of these genes, nisA en-
codes the nisin A precursor peptide of 57 amino acid residues;
nisB and nisC encode putative enzymes involved in the post-
translational modification reactions (based on homology to
genes found exclusively in other lantibiotic gene clusters); nisT
encodes a putative transport protein of the ABC translocator
family that is probably involved in the extrusion of modified
precursor nisin (7, 9); nisP encodes an extracellular subtilisin-
like protease involved in precursor processing (8); nisI encodes
a lipoprotein involved in the producer self-protection against
nisin (9); and nisFEG encodes putative transporter proteins
that have also been implied in immunity (11). A schematic
representation of the post-translational events yielding mature
nisin A is shown in Fig. 1B. Nisin Z is a natural variant of nisin
A that contains an asparagine residue at position 27 instead of
the histidine residue found in nisin A (12). Both nisin A- and
nisin Z-producing strains are common in nature, and both
structural genes (nisA and nisZ) have been cloned (5, 6, 13).
The proteins encoded by nisR (8) and nisK (10) have shown to
be involved in the regulation of nisin biosynthesis (8, 10). NisR
is a response regulator, and NisK is a sensor histidine kinase
which belong to the class of two-component regulatory systems
(14–16). When the genes nisABTCIR are present on a multi-
copy plasmid, production of fully modified precursor nisin is
observed, indicating that overexpression of nisR alone is suffi-
cient to activate transcription of nisA and obviously also of the
biosynthetic genes downstream by partially reading through
an inverted repeat sequence (Fig. 1A) (8). This observation is
similar to the regulation of expression of iep and degU genes in
Bacillus subtilis, where overexpression of the response regula-
tor activates transcription of the target genes (17), and to the
case of overexpression of epiQ, which encodes a response reg-
ulator involved in the biosynthesis of the lantibiotic epidermin
(18). When only the genes nisABTCI are present on a multicopy
plasmid (pNZ9000) in Lactococcus lactis MG1614, no transcrip-
tion of nisA is observed (9). Two gene products have been
identified for the regulation of the biosynthesis of the related
lantibiotic subtilin (19), which also belong to the class of two-
component regulators, i.e. SpaR, the response regulator, and
SpaK, the sensor histidine kinase (20, 21). Upon disruption of
either of these genes, subtilin production was abolished, indi-
cating the involvement of these gene products in sub-
tilin biosynthesis (20). The regulation was shown to be
growth-phase dependent, but an inducing signal was not
identified (20, 21).
While the structure and function of two-component regula-
tors have been studied in great detail (14–16), the nature of the
inducing signal has remained unclear in many cases. It is
demonstrated here that fully modified nisin can induce the
transcription of its own structural gene as well as of the down-
stream genes by limited read-through, via signal transduction,
by acting as the extracellular signal for the sensor histidine
kinase NisK.
MATERIALS AND METHODS
Strains and Plasmids—L. lactis strains MG1614 (22), NZ9700 (a
nisin-producing transconjugant containing Tn5276) (23), and NZ9800
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 FIG.1 .A , organization of the nisin gene cluster. Established (nisAIPRKFEG) and putative (nisBCT) functions of the gene products have been
indicated. P denotes a mapped promoter, and IR denotes an extensive inverted repeat sequence that could act as a rho-independent terminator (7).
B, schematic outline of the biosynthesis of nisin A. Rings are labeled A–E. Asterisks indicate residues that will be modified. The black arrow
indicates processing of the N-terminal Met residue, while the small white arrow indicates processing of the leader peptide by the action of NisP
(8). Dha, dehydroalanine; Dhb, dehydrobutyrine.









































































 (a derivative of NZ9700 in which the nisA gene has been exchanged by
replacement recombination with a modified nisA gene containing a
4-bp
1 deletion in the pronisin-encoding part (DnisA) and which is
therefore no longer able to produce nisin A) have been described previ-
ously (9). L. lactis strains were cultivated without aeration at 30 °C in
M17 broth (Difco) supplemented with 0.5% (w/v) glucose (GM17) or
sucrose (SM17). For L. lactis strains harboring pNZ273-derived plas-
mids (24), media were supplemented with 10 mg/ml chloramphenicol.
Expression plasmids pNZ9010 and pNZ9013 (9, 25), containing the
nisA and nisZ genes, respectively, under control of the efficient lac
promoter, were introduced into L. lactis strain NZ9800, leading to the
production of nisin A or nisin Z in similar amounts as in L. lactis
wild-type strain NZ9700 (25). As a host strain for cloning experiments,
Escherichia coli strain MC1061 (26) was used.
The nisA promoter region including part of the nisA gene was iso-
lated as a 1442-bp BglII-Ecl136II fragment from plasmid pNZ9000 (8).
This fragment was cloned into pNZ273, containing the promoterless
gusA gene (24), which had been digested with BglII and ScaI, generat-
ing plasmid pNZ8003. Part of the upstream promoter region was de-
leted by digesting pNZ8003 with BglII and Tth111I. These sites were
made blunt by Klenow polymerase and ligated, generating plasmid
pNZ8008, which eventually contained a 312-bp nisA promoter fragment
in front of the gusA gene. Another part of the nisA promoter region,
including the full nisA gene and the first part of the nisB gene, was
isolated as a 1904-bp BglII-MunI fragment from plasmid pNZ9000.
This fragment was cloned into pNZ273 (24), which had been digested
with BglII and EcoRI, generating plasmid pNZ8002. A 1442-bp BglII-
Ecl136II promoter fragment was deleted in pNZ8002, generating
pNZD8002, by making the BglII site blunt with Klenow polymerase and
subsequent ligation to the Ecl136II site. All constructs were initially
made in E. coli MC1061 (26). Plasmids pNZ8008, pNZ8002, and
pNZD8002 were used to transform L. lactis NZ9700 and L. lactis
NZ9800 (9), and transformants were obtained by selecting for resist-
ance to chloramphenicol.
DNA Techniques and DNA Sequence Analysis—Restriction enzymes
and other DNA-modifying enzymes were purchased from Life Technol-
ogies, Inc. or U. S. Biochemical Corp. and used as recommended by the
manufacturers. The DNA sequence of the nisZ region was determined
on the double-stranded plasmid DNA with the HindIII primer by the
chain termination method (27). Transcription analyses of the nisA and
DnisA genes were performed by isolation of RNA from L. lactis strains
NZ9700 and NZ9800, Northern blotting, and subsequent hybridization
with a radiolabeled nisA probe as described previously (9). RNA isola-
tion was performed 2 h after induction of a culture with an A600 nm of
0.5. RNA (20 mg) was loaded in each lane, and the amounts were
estimated by comparing the intensity of the 16 S and 23 S RNA bands.
Inactivation of Chromosomal nisK and nisB by Gene Replacement—
The chromosomal copy of the nisK gene was inactivated by introduction
of an erythromycin resistance gene (28) into the open reading frame of
nisK. For this purpose, a 2.8-kilobase pair HindIII-EcoRI chromosomal
DNA fragment from strain NZ9700 containing the 39-part of the nisP
gene and the intact nisR and nisK genes was cloned into pUC19. The
erythromycin resistance gene was introduced into a unique SalI site,
resulting in the interruption of the nisK open reading frame between
the encoded amino acids 9 and 10 of NisK and leaving 1.1 and 1.7
kilobase pairs of flanking regions at the 59- and 39-ends, respectively.
This construct was designated pNZ9150. Strain NZ9800 was trans-
formed with the nonreplicating plasmid pNZ9150, and integrants were
selected on plates containing erythromycin (2.5 mg/ml). The selected
integrants were analyzed by polymerase chain reaction using primers
59-CGGTCAATCTCGGAG-39 and 59-CGCTTTGTAATCATTTTCATC-39
and by Southern hybridization using pUC19 DNA (29) as a probe. In
one of the strains (NZ9850), the erythromycin resistance gene had been
integrated via gene replacement at the 39- and 59-flanking regions,
introducing this gene into the open reading frame of the chromosomal
copy of the nisK gene, in the absence of any pUC19 sequences. The
resulting construct was further analyzed by polymerase chain reaction
of the nisK region and by Southern blotting using nisK as a probe to
confirm the desired configuration.
The nisB gene was disrupted by introducing a 162-bp in-frame dele-
tion into the middle of the gene. This was accomplished by cloning a
4.4-kilobase pair BglII-EcoRI fragment, containing nisB and surround-
ing regions from the nisin gene cluster, into a BamHI-EcoRI-digested
pUC19 vector, which harbored an additional erythromycin resistance
marker, as has been described previously (9). The deletion was made by
removing an internal HpaI fragment from the nisB gene and subse-
quent ligation. The resulting plasmid was named pNZ9135 and was
used for transformation of L. lactis NZ9700. Following transformation,
erythromycin-resistant colonies were obtained that had integrated the
plasmid by recombination of the plasmid with one of the flanking
regions of the deleted fragment. After growing for 200 generations in
the absence of erythromycin and plating, a colony was obtained that
was sensitive to erythromycin. This had apparently been caused by a
second recombination event involving the flanking region on the other
side of the deletion than the side of the first recombination event,
resulting in the replacement of nisB with DnisB on the chromosome.
The configuration of the desired construct was confirmed by polymerase
chain reaction analysis of the nisB region with the deletion and by
Southern analysis of BglII-digested chromosomal DNA. The desired
strain was called NZ9700 DnisB.
Production, Purification, and Characterization of Nisin Mutants—
Mutants of nisin Z were produced as described previously (25). The





(mutated nucleotides are indicated in boldface). All mutants were
purified to homogeneity, and the structures of the modified residues
were confirmed by one- and two-dimensional
1H NMR (25). It was
established that T2S nisin Z contains a dehydroalanine residue at
position 2, S3T nisin Z has a b-methyllanthionine ring between
residues 3 and 7 instead of a lanthionine, and I1W nisin Z and M17W
nisin Z contain a Trp residue at positions 1 and 17, respectively.
Precursor nisin Z, containing the subtilin leader peptide (sl-nisin Z),
was obtained as described before (30). Purified lacticin 481 was
isolated as described previously (31, 32). Purified Pep5 (33) was
obtained from Dr. H.-G. Sahl (Bonn, Germany). Unmodified precur-
sor nisin A was obtained from the laboratory of Dr. G. Jung (Tu ¨bin-
gen, Germany). Preparations of subtilin (19) and lactococcin A (34)
consisted of culture supernatants of producing strains, which were
confirmed to possess substantial antimicrobial activity in agar diffu-
sion assays. Antimicrobial activities against L. lactis MG1614 were
determined essentially as described before for Micrococcus flavus
(25). L. lactis was cultured in GM17 broth at 30 °C with an initial
A600 nm of 0.025, and outgrowth was measured when the culture
without nisin had reached an A600 nm of 0.8.
b-Glucuronidase Assays—Lactococcal cells (1 ml) were harvested at
1.5 h after induction with nisin (or mutants or fragments or other
antimicrobial species) and adjusted in NaPi buffer (50 mM NaHPO4,p H
7.0) to a final A600 nm of 2.0. The cells were permeabilized by adding 50
ml of acetone/toluene (9:1) per ml of cells followed by 10 min of incuba-
tion at 37 °C. The extracts were used immediately in the assay. For the
determination of b-glucuronidase activity, 40 ml of extract was added to
950 ml of buffer (50 mM NaHPO4, pH 7.0, 10 mM b-mercaptoethanol, 1
mM EDTA, 0.1% Triton X-100) and 10 ml of 100 mM p-nitro-b-D-glucu-
ronic acid (CLONTECH, Palo Alto, CA). The mixture was incubated,
and the increase in A405 nm was measured at 37 °C. Histochemical
screening for gusA positive colonies was performed by including 5-bro-
mo-4-chloro-3-indolyl glucuronide (Research Organics Inc., Cleveland,
OH) at a final concentration of 0.5 mM in GM17 plates (24). Purified
nisin fragments (35–39) were obtained from Prof. T. Shiba (Protein
Research Foundation, Osaka, Japan).
RESULTS AND DISCUSSION
Transcription Analyses of DnisA in the Presence and Absence
of Nisin or Nisin Mutants—The promoter sequence and the
transcription start site of nisA have been identified, and a
transcript of ;260 nucleotides has been demonstrated in L.
lactis strain NZ9700, which contains Tn5276 (9). It has also
been found that transcription of nisA is dependent on the
integrity of nisA itself since a 4-bp deletion in the middle of the
nisA gene (DnisA) on the chromosome of L. lactis strain NZ9800
completely abolishes transcription of this gene (9). For further
transcription analyses of the structural and biosynthetic genes,
a series of isogenic lactococcal strains was used, including the
nisin-producing NZ9700 and non-nisin-producing NZ9800
strains.
Northern blotting showed that in strain NZ9800, the tran-
script of DnisA was absent, but after adding small amounts of
1 The abbreviation used is: bp, base pair(s).









































































 nisin A to the culture medium at an A600 nm of 0.5, nisA tran-
scripts appeared again (Fig. 2). Interestingly, the amount of
these transcripts was dependent on the amount of nisin A
added (Fig. 2, lanes 3–7). Several other related peptides were
able to induce transcription, such as nisin Z and various nisin
Z mutants, i.e. T2S nisin Z, S5T nisin Z (25), M17W nisin Z,
S3T nisin Z, and sl-nisin Z, a fully modified nisin Z species that
has the subtilin leader peptide still attached (30). However, the
last two species were .100-fold less effective inducers com-
pared with nisin Z (data not shown). In contrast, the T2S and
M17W nisin Z mutants were more potent inducers than nisin Z.
These findings demonstrate that the modified lantibiotic part
plays an important role in the induction process. Interestingly,
several less related peptides evoked no restoration of transcrip-
tion, i.e. the unmodified synthetic nisin A precursor of 57 amino
acid residues (Figs. 1B and 2, lane 12), the 56% homologous
lantibiotic subtilin (19), the lantibiotic lacticin 481 (31, 32), the
lantibiotic Pep5 (Fig. 2, lane 13) (33), and the antimicrobial
peptide lactococcin A (34) (data not shown for subtilin, lacticin
481, and lactococcin A).
Determination of the Induction Capacity of Nisin (Mutants)
by Use of the Nisin Promoter Fragment Fused to the Reporter
Gene gusA—To obtain a more quantitative assay of induction
capacity and to investigate whether the nisA promoter could be
used to regulate expression of heterologous genes in L. lactis,a
nisin promoter fragment of 312 bp containing part of the nisA
structural gene was fused to the promoterless reporter gene
gusA of E. coli on plasmid pNZ273 (24). This construct, named
pNZ8008, was used to transform strain NZ9800. The resulting
strain was assayed for b-glucuronidase activity with and with-
out induction by (mutant) nisins or other antimicrobial pep-
tides. Without induction, b-glucuronidase activity could not be
demonstrated, whereas wild-type nisin A and nisin Z effec-
tively induced b-glucuronidase activity (Fig. 3). Moreover, the
T2S and M17W nisin Z mutants were found to induce higher
expression of gusA compared with wild-type nisin A and nisin
Z, whereas the S3T and I1W nisin Z mutants were found to
have lower induction capacity (Fig. 3). It was calculated that
,5 molecules of the best inducer (T2S nisin Z) per cell are
sufficient to activate transcription, which illustrates the high
efficiency characteristic of signal transduction processes. Con-
cordant with the transcription analyses, some of the antimicro-
bial peptides tested did not elicit induction of gusA expression
(i.e. the unmodified synthetic nisin A precursor peptide, subti-
lin, lacticin 481, and lactococcin A). There is no direct relation-
ship between antimicrobial activity of the nisin mutants
against L. lactis strain MG1614 and their induction capacity
(Table I). The difference in potency can be attributed to the
observation that antimicrobial activity is dependent on pore-
forming activity in membranes (40–42), while induction capac-
ity is likely to be dependent on interaction (directly or indi-
rectly) with NisK.
In further experiments, the nisin-producing strain NZ9700
with either plasmid pNZ273 (containing the promoterless gusA
gene) or pNZ8008 (containing the nisA promoter fragment fol-
lowed by the gusA gene) was used in an agar diffusion assay (8)
to determine the amount of nisin produced. Fifty times lower
nisin production and severely reduced immunity were observed
when plasmid pNZ8008 was present compared with the situa-
tion where pNZ273 was present. This can be explained by
titration of the response regulator NisR by the multicopy pres-
ence of the nisA promoter region containing the putative NisR-
binding site.
Structural Requirements of the Inducer Molecule Tested by
Use of Synthetic Nisin Fragments—More detailed insight into
FIG.2 .Northern blot prepared using nisA as a probe of RNA
from several uninduced lactococcal cultures and cultures in-
duced with different amounts of nisin A or unmodified precur-
sor nisin A or with the lantibiotic Pep5. Lane 1, NZ9700 (nisin A
producer); lane 2, MG1614; lanes 3–7, NZ9800 with nisin A (0, 1, 2.5, 10,
and 50 ng/ml, respectively); lanes 8 and 9, NZ9800 DnisK with nisin A
(0 and 2.5 ng/ml, respectively); lanes 10 and 11, NZ9700 DnisB with
nisin A (0 and 2.5 ng/ml, respectively); lane 12, NZ9800 with unmodi-
fied precursor nisin A (1000 ng/ml); lane 13, NZ9800 with Pep5
(1000 ng/ml).
FIG.3 .Dose response of purified (mutant) nisins as inducers
of gusA expression in L. lactis strain NZ9800 harboring
pNZ8008. Nisin species were as follows: , T2S nisin Z; M, M17W nisin
Z; E, wild-type nisin Z; L, S3T nisin Z; , I1W nisin Z. Standard errors
were ,20% for each given value. A.U., arbitrary units.
TABLE I
Comparison of induction capacity with antimicrobial activity against
L. lactis strain MG1614 or against M. flavus of nisin Z, nisin Z
mutants, and synthetic nisin A fragments (36)





T2S nisin Z 1100 78 All
M17W nisin Z 220 12 All
Nisin Z 100 100 All
S3T nisin Z 11 2 All
I1W nisin Z 3 47 All
Nisin A fragments




Nisin A 100 100 A–E
1–21 30 ,50 A–C
1–19 8 ,25 A–C
1–11 2 ,1A , B






d ,1B , C
22–34 ND
d ,1D , E
a The induction capacity of nisin Z was taken as 100%; values were
calculated by measuring the distances between the dose-response
curves of nisin Z and each of the nisin species.
b The minimal inhibitory concentration of nisin Z against L. lactis
MG1614 (14 ng/ml) or against M. flavus (11 ng/ml) was taken as 100%
activity. All nisin fragments contained the modified residues as they are
present in wild-type nisin A (Fig. 1B), unless indicated otherwise, at
position 5. Standard errors were ,20% for each given value.
c Values are taken from Ref. 36.
d ND, not detectable.









































































 the minimal structural requirements of the inducer molecule
was obtained by using synthetic nisin A fragments (35–39) in
the gusA reporter assay (Table I). The minimal requirement for
retaining induction capacity (2% induction of that of nisin A)
was the presence of residues 1–11 of nisin A, comprising the
first two rings. Addition of the third ring enhanced induction
(8–30% induction), whereas a severe decrease in induction was
caused by deleting the N-terminal residues Ile-1 and dehydro-
butyrine 2 (0–1% induction) (Table I). Fragments that con-
tained rings B and C or rings D and E (for nomenclature of
rings, see Fig. 1B) were not capable of acting as a signal
effector. Thus, the most probable site of molecular interaction
with the sensor protein NisK will be residues 1–11 of the nisin
molecule.
Requirement of nisK Expression for Signal Transduction—
The sequence of the nisK gene located on Tn5276 has been
reported (43) and was found to be identical to that of nisK from
L. lactis 6F3 (10). The chromosomal nisK gene was insertion-
ally inactivated by introduction of an erythromycin resistance
gene (28) into strain NZ9800, yielding strain NZ9850. As ex-
pected, transcription of DnisA was no longer inducible by any of
the nisin species (Fig. 2, lanes 8 and 9). Nisin production in
strain NZ9850 could not be restored by introduction of plasmid
pNZ9010 (nisA) or pNZ9013 (nisZ), whereas it could be re-
stored in strain NZ9800. Since the immunity level of strain
NZ9850 is similar to that of strain MG1614 (0.01 mg of nisin
A/ml), induction experiments were performed with amounts of
nisin well below this level. Under these conditions, normal
growth of the cells was observed. Strain NZ9850 was also
transformed with pNZ8008, but after induction with 0.0005–
0.0025 mg of nisin A/ml, no b-glucuronidase activity could be
measured (,0.3 arbitrary unit), indicating at least 200 times
lower expression than in strain NZ9800 containing pNZ8008,
with the same inducer concentrations (Fig. 3). No polar effects
of the nisK disruption on expression of the nisFEG genes down-
stream of nisK are expected since a promoter has been indi-
cated in front of nisFEG (11).
2 Moreover, the nisR and nisK
genes have been integrated on the chromosome of strain
MG1614 by replacement recombination, and the resulting
strain was transformed by pNZ8008. In this strain, gusA ex-
pression was inducible by nisin species (data not shown), prov-
ing that only nisR and nisK are required for signal transduc-
tion. These results clearly demonstrate that NisK is essential
in the signal transduction pathway and probably interacts
directly with nisin itself.
Effects of Disruption of nisB on Transcription of nisA and
Downstream Genes—An in-frame deletion in the nisB gene of
L. lactis strain NZ9700, made by replacement recombination,
abolished nisin production as well as transcription of nisA,
demonstrating that a hampered biosynthesis of nisin abolishes
transcription of nisA. In this case, transcription of nisA could
be restored by addition of nisin to the cells (Fig. 2, lane 11),
probably because of the presence of intact nisR and nisK genes,
which have their own promoter. The transcription start site of
nisRK was mapped by primer extension and shown to be an A
nucleotide 26 nucleotides upstream of the start codon of nisR
(position 2117 in the nucleotide sequence published in Ref. 8).
To probe the influence of a large inverted repeat sequence
located in the intergenic region between DnisA and nisB on
expression of genes downstream of DnisA (Fig. 1A), another
plasmid was constructed (pNZ8002) in which the nisin pro-
moter fragment including DnisA as well as the intergenic re-
gion and the first part of nisB was fused to the gusA gene. This
plasmid was able to direct expression of gusA in strain NZ9800
only after induction with nisin species, albeit to an ;50-fold
reduced level relative to gusA expression in pNZ8008 in strain
NZ9800. When the nisin promoter fragment was removed from
pNZ8002, yielding pNZD8002, b-glucuronidase activity was
completely abolished, even in the presence of an inducer. These
results show that expression of at least one downstream gene,
i.e. nisB, is coregulated and is dependent on the presence of the
nisA promoter. Most likely, expression of the other downstream
genes nisTCIP limited read-through is also dependent on the
nisA promoter since a significant increase in immunity levels,
for which NisI is partially responsible (9), was found in the
induced state relative to the uninduced state of strain NZ9800.
Moreover, no apparent promoter sequences were found in front
of any of the genes nisBTCIP.
Conclusion—We have demonstrated that transcription of
nisA is autoregulated, not intracellularly by its direct transla-
tion product, but extracellularly by the secreted and fully mod-
ified peptide via signal transduction by a two-component reg-
ulatory system. A model based on previous work (5–11) and on
this study shows the possible sequence of events with regard to
nisin biosynthesis and regulation (Fig. 4).
Mutants of nisin or precursors of nisin that have the leader
peptide attached to the mature lantibiotic (second molecule
shown in Fig. 1B) can also act as inducers, whereas other
antimicrobial peptides are incapable of induction. The presence
of the modified residues is of crucial importance for induction
capacity, especially those present in the N-terminal part of
nisin. To our knowledge, this is the only report of peptides that
can induce transcription of their own structural gene via signal
transduction. Interestingly, a recent report on syndecan bio-
synthesis in mice, which plays a role in wound repair, describes
the role of the antimicrobial peptide PR39 in induction of syn-
decan gene transcription (44), although the amount of inducer
needed (0.5 mM) is at least a factor of 10,000 higher than for
nisin (30 pM). This suggests that the role of antimicrobial
peptides in nature might be broader than just the antagonistic
action because in some cases these peptides can also act as
signals for transcription activation of their own structural gene
2 P. G. G. A. de Ruyter, O. P. Kuipers, and W. M. de Vos, unpublished
data.
FIG.4 .Model for nisin biosynthesis and regulation. In Step 1,
NisK senses the presence of nisin in the medium and autophosphoryl-
ates. In Step 2, the phosphate group is transferred to NisR, which acts
as a transcriptional activator, followed by mRNA synthesis and riboso-
mal synthesis of unmodified precursor nisin and of biosynthetic pro-
teins. In Step 3, the precursor is modified by the putative enzymes NisB
and NisC (7, 9). In Step 4, the fully modified precursor peptide is
translocated across the membrane by the putative ABC transporter
NisT (7, 9). In Step 5, fully modified precursor nisin is extracellularly
processed by NisP (8), resulting in the release of active nisin. NisI (9),
together with NisF, NisE, and NisG (11), protects the cell from the
bacteriocidal action of nisin by a thus far unknown mechanism.









































































 or of other genes. There may be several evolutionary reasons
for the autoregulation of nisin gene transcription via signal
transduction, e.g. (i) to save energy by control of the integrity of
the gene cluster since any dysfunctional biosynthetic gene will
abolish inducer formation and thus expression of biosynthetic
genes; (ii) to raise immunity levels in response to high nisin
production by neighboring cells, in other words, to amplify the
response to environmental signals; or (iii) to promote cell to cell
communication that allows the production of antimicrobial
peptides in high quantities in a concerted action, thereby de-
creasing the chance of resistance development in target
organisms.
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